Humulin r and Platelet distribution width increased - a phase IV clinical study of FDA data

Summary:

Platelet distribution width increased is reported as a side effect among people who take Humulin r (insulin recombinant human), especially for people who are male, 60+ old, also take Allopurinol,.

The phase IV clinical study analyzes which people have Platelet distribution width increased when taking Humulin r. It is created by eHealthMe based on reports of 22,077 people who have side effects when taking Humulin r from the FDA, and is updated regularly.

What is Humulin r?

Humulin r has active ingredients of insulin recombinant human. It is often used in type 1 diabetes. eHealthMe is studying from 22,147 Humulin r users. Check the latest studies of Humulin r.

What is Platelet distribution width increased?

Platelet distribution width increased is found to be associated with 19 drugs and 25 conditions by eHealthMe. Check the latest studies of Platelet distribution width increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

22,077 people reported to have side effects when taking Humulin r.
Among them, 12 people (0.05%) have Platelet distribution width increased.

Could Humulin r cause Platelet distribution width increased?

Among these 12 people:

What is the gender of people who have Platelet distribution width increased when taking Humulin r? *

female: 0.0 %
male: 100 %

What is the age of people who have Platelet distribution width increased when taking Humulin r? *

What are other drugs people take besides Humulin r? *

Torsemide: 12 people, 100.00%
Telmisartan: 12 people, 100.00%
Finasteride: 12 people, 100.00%
Eplerenone: 12 people, 100.00%
Apixaban: 12 people, 100.00%
Allopurinol: 12 people, 100.00%
Tamsulosin: 10 people, 83.33%
Omeprazole: 6 people, 50.00%
Pantoprazole Sodium: 4 people, 33.33%
Tamsulosin Hydrochloride: 2 people, 16.67%

What are other side effects people have besides Platelet distribution width increased? *

Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 12 people, 100.00%
Rales (an abnormal respiratory sound characterized by fine crackles): 12 people, 100.00%
Oedema Peripheral (superficial swelling): 12 people, 100.00%
Monocyte Count Increased: 12 people, 100.00%
Dyspnea Exertional: 12 people, 100.00%
C-Reactive Protein Increased: 12 people, 100.00%
Arrhythmias (irregular heartbeat): 12 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Humulin r and have Platelet distribution width increased?

- Check whether Platelet distribution width increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Humulin r:

Humulin r (22,147 reports)

Browse all side effects of Humulin r:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Platelet distribution width increased:

Platelet distribution width increased (19 drugs)

Browse all the conditions that are associated with Platelet distribution width increased:

Platelet distribution width increased (25 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin recombinant human (the active ingredients of Humulin r) and Humulin r (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.